ALFIYA HASU: Open Payments
NPI 1326562414 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 19 payments from 7 companies in 2025. Trend: 2023 $100 · 2024 $341 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $239 |
| Dendreon Pharmaceuticals LLC | 4 | $110 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Stryker Corporation | 1 | $42 |
| Boston Scientific Corporation | 1 | $37 |
| PFIZER INC. | 1 | $24 |
| Caris MPI, Inc. | 1 | $19 |
Products named: Korlym, PROVENGE, GEMTESA, PROCUITY, SpaceOAR VUE System - 10mL, XTANDI, MI CANCER SEEK.
Industry payments across DC — which companies pay providers there.
